Evidence map›Paper›PMID 34879076›Full record

ArticlePLoS computational biology2021

Development of an experiment-split method for benchmarking the generalization of a PTM site predictor: Lysine methylome as an example.

Guoyang Zou, Yang Zou, Chenglong Ma, Jiaojiao Zhao, Lei Li

Abstract read
In one paragraph

Article in PLoS computational biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guoyang ZouSchool of Basic Medicine, Qingdao University, Qingdao, China.ORCID 0000-0003-0736-8759
Yang ZouSchool of Basic Medicine, Qingdao University, Qingdao, China.ORCID 0000-0002-8569-8780
Chenglong MaCollege of Life Science, Qingdao University, Qingdao, China.
Jiaojiao ZhaoSchool of Basic Medicine, Qingdao University, Qingdao, China.
Lei LiSchool of Basic Medicine, Qingdao University, Qingdao, China.ORCID 0000-0003-0266-8939

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many computational classifiers have been developed to predict different types of post-translational modification sites. Their performances are measured using cross-validation or independent test, in which experimental data from different sources are mixed and randomly split into training and test sets. However, the self-reported performances of most classifiers based on this measure are generally higher than their performances in the application of new experimental data. It suggests that the cross-validation method overestimates the generalization ability of a classifier. Here, we proposed a generalization estimate method, dubbed experiment-split test, where the experimental sources for the training set are different from those for the test set that simulate the data derived from a new experiment. We took the prediction of lysine methylome (Kme) as an example and developed a deep learning-based Kme site predictor (called DeepKme) with outstanding performance. We assessed the experiment-split test by comparing it with the cross-validation method. We found that the performance measured using the experiment-split test is lower than that measured in terms of cross-validation. As the test data of the experiment-split method were derived from an independent experimental source, this method could reflect the generalization of the predictor. Therefore, we believe that the experiment-split method can be applied to benchmark the practical performance of a given PTM model. DeepKme is free accessible via https://github.com/guoyangzou/DeepKme.

Indexed as

LysineModels, GeneticBenchmarkingComputational BiologyDeep LearningEpigenomeHumansMethylationProtein Processing, Post-TranslationalProteomeLysineProteome

Identifiers

PMID34879076
PMCPMC8687584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.